The pediatric bladder treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Pediatric Bladder Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The pediatric bladder treatment market size has grown strongly in recent years. It will grow from $3.36 billion in 2023 to $3.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to prevalence of pediatric bladder conditions, growing awareness of pediatric bladder conditions, increasing access to healthcare for children, rising disposable incomes.
The pediatric bladder treatment market size is expected to see steady growth in the next few years. It will grow to $4.23 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to aging population, rising prevalence of chronic diseases in children, increasing access to healthcare, demand for personalized medicine in the treatment. Major trends in the forecast period include adoption of new and innovative pediatric bladder treatments, digital health technologies, early intervention and prevention, non-invasive treatments.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report
Scope Of Pediatric Bladder Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Pediatric Bladder Treatment Market Overview
Market Drivers –
The increasing prevalence of pediatric bladder disorders is expected to propel the growth of the pediatric bladder treatment market going forward. Pediatric bladder disorders refer to various medical conditions that impact the normal functioning of the urinary bladder in children. Conditions such as spina bifida and neurological disorders contribute to urinary problems in children, necessitating effective treatments. For instance, in March 2023, according to a journal published by the Multidisciplinary Digital Publishing Institute (MDPI), a Switzerland-based publishing company, in a study involving 1,065 pediatric patients with neurogenic bladder (NGB), 38.9% of patients had spina bifida. The primary complication observed was lower urinary tract infection (18.1%), particularly prevalent among patients with open spina bifida (54.1%). Moreover, over a 12-month follow-up, common prevalent complications included lower urinary tract infections (18.1%), urinary incontinence (8.0%) and hydronephrosis (5.6%), with 7.9% of patients facing four or more recurring lower urinary tract infections. Therefore, the increasing prevalence of pediatric bladder disorders will drive the growth of the pediatric bladder treatment market.
Market Trends –
Major companies operating in the pediatric bladder treatment market are developing targeted therapies to address specific medical conditions in the pediatric population and provide tailored solutions for unique patient demographics and medical needs. Targeted therapies in pediatric bladder treatment refer to the specialized and precise medical interventions designed to effectively address children with bladder disorders’ unique challenges and requirements. For instance, in March 2021, Astellas Pharma Inc., a Japan-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron extended-release oral suspension) for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients aged three years and older. Neurogenic detrusor overactivity (NDO) is a form of bladder dysfunction stemming from nerve damage that manifests through involuntary bladder contractions, resulting in symptoms such as frequent urination, an urgent need to urinate and urinary incontinence. Myrbetriq tablets (Mirabegron extended-release tablets) are presently accessible in the U.S. market.
The pediatric bladder treatment market covered in this report is segmented –
1) By Type: Diurnal Incontinence; Enuresis; Other Types
2) By Treatment: Urotherapy; Medication; Surgical Reconstruction; Other Treatments
3) By Route of Administration: Oral; Parenteral; Other Route of Administrations
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Get an inside scoop of the pediatric bladder treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12943&type=smp
Regional Insights –
North America was the largest region in the pediatric bladder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the pediatric bladder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cook Medical Inc., Ipsen Pharma, Aurobindo Pharma Ltd., Endo International PLC, Coloplast AIS, Endo International PLC, Apotex Inc., Amneal Pharmaceuticals LLC., Orion Corporation, Taro Pharmaceuticals, Laborie Medical Technologies Corp., Salix Pharmaceuticals, TherapeuticsMD Inc., UroGen Pharma, Palette Life Sciences, Sumitovant Biopharma.
Table of Contents
1. Executive Summary
2. Pediatric Bladder Treatment Market Report Structure
3. Pediatric Bladder Treatment Market Trends And Strategies
4. Pediatric Bladder Treatment Market – Macro Economic Scenario
5. Pediatric Bladder Treatment Market Size And Growth
…..
27. Pediatric Bladder Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
